D.E. Shaw & Co’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-74,788
| Closed | -$1.33M | – | 4214 |
|
|
2018
Q3 | $1.33M | Sell |
74,788
-602,215
| -89% | -$10.3M | ﹤0.01% | 2493 |
|
|
2018
Q2 | $9.34M | Sell |
677,003
-937,556
| -58% | -$11.1M | 0.02% | 1114 |
|
|
2018
Q1 | $14.7M | Sell |
1,614,559
-462,943
| -22% | -$2.55M | 0.02% | 801 |
|
|
2017
Q4 | $8.89M | Buy |
2,077,502
+1,660,361
| +398% | +$7.91M | 0.02% | 1106 |
|
|
2017
Q3 | $588K | Buy |
417,141
+194,182
| +87% | +$271K | ﹤0.01% | 2822 |
|
|
2017
Q2 | $334K | Sell |
222,959
-94,435
| -30% | -$203K | ﹤0.01% | 2992 |
|
|
2017
Q1 | $816K | Sell |
317,394
-40,154
| -11% | -$92.9K | ﹤0.01% | 2444 |
|
|
2016
Q4 | $912K | Buy |
357,548
+25,957
| +8% | +$74.5K | ﹤0.01% | 2516 |
|
|
2016
Q3 | $1.02M | Buy |
331,591
+73,371
| +28% | +$229K | ﹤0.01% | 2370 |
|
|
2016
Q2 | $829K | Sell |
258,220
-34,514
| -12% | -$126K | ﹤0.01% | 2523 |
|
|
2016
Q1 | $907K | Buy |
292,734
+48,511
| +20% | +$158K | ﹤0.01% | 2416 |
|
|
2015
Q4 | $980K | Buy |
244,223
+131,337
| +116% | +$605K | ﹤0.01% | 2642 |
|
|
2015
Q3 | $517K | Buy |
112,886
+32,123
| +40% | +$168K | ﹤0.01% | 3040 |
|
|
2015
Q2 | $419K | Sell |
80,763
-18,078
| -18% | -$108K | ﹤0.01% | 3254 |
|
|
2015
Q1 | $618K | Buy |
98,841
+32,930
| +50% | +$190K | ﹤0.01% | 2930 |
|
|
2014
Q4 | $415K | Buy |
65,911
+55,011
| +505% | +$335K | ﹤0.01% | 3455 |
|
|
2014
Q3 | $66K | Buy |
+10,900
| New | +$74.4K | ﹤0.01% | 4011 |
|
|
2014
Q2 | – | Sell |
-36,645
| Closed | -$873K | – | 4801 |
|
|
2014
Q1 | $873K | Buy |
+36,645
| New | +$531K | ﹤0.01% | 3149 |
|